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propagate cephalad to where patency of the ICA can be
maintained by collateral flow, commonly occurring at the
level of the ophthalmic artery. Reviews of the surgical
treatment for ICA occlusions have been historic and have
shown mostly dismal results.4-7
Patients with acute ICA occlusions can have a vari-
able presentation ranging from asymptomatic to pro-
found neurologic impairment and death. In addition,
long-term patient neurologic outcome is unpredictable.
The retrospective reviews of operative intervention in
patients with acute ICA occlusions and neurologic events
have often shown worse outcomes when compared with
medical management of matched patients.4-7 However, a
few reports, including our previously published data,
have shown a benefit to urgent CTEA in appropriately
selected patients.8-12 In this article we review our past
decade of experience in the management of patients with
acute ICA occlusion.
METHODS
Twenty-nine patients presenting with acute neurologic
symptoms were thought to have recent total occlusion of
The efficacy of carotid thromboendarterectomy
(CTEA) for acute carotid occlusion has not been estab-
lished. Although several randomized studies regarding the
management of symptomatic and asymptomatic patients
with hemodynamically significant internal carotid artery
(ICA) stenosis have validated the use of operative
endarterectomy, the same conclusion has not been
attained for patients with ICA occlusions.1-3
ICA occlusions usually occur at a point of critical
stenosis in the proximal ICA. Often the thrombus will
From the Department of Surgery and the John J. Cranley Vascular
Laboratorya; the Neurology Departmentb; and the Neuroradiology
Department, Good Samaritan Hospital.c
Competition of interest: nil.
Presented at the Joint Annual Meeting of the American Association for
Vascular Surgery and the Society for Vascular Surgery, Toronto, Canada,
Jun 11, 2000.
Reprint requests to: Gregory C. Kasper, MD, c/o Kim Hasselfeld,
Research 11J, Good Samaritan Hospital, 375 Dixmyth Avenue,
Cincinnati, OH 45220 (e-mail: kimberly_hasselfeld@trihealth.com).
Copyright © 2001 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2001/$35.00 + 0 24/6/112213
doi:10.1067/mva.2001.112213
Carotid thromboendarterectomy for recent total
occlusion of the internal carotid artery
Gregory C. Kasper, MD,a Alan R. Wladis, MD,a Joann M. Lohr, MD,a L. Richard Roedersheimer,
MD,a Robert L. Reed, MD,b Timothy J. Miller, MD,c and Richard E. Welling, MD,a Cincinnati, Ohio
Background: The efficacy of emergency carotid thromboendarterectomy (CTEA) for acute internal carotid artery (ICA)
thrombosis has been questioned. We evaluated the use of CTEA in patients with recent ICA occlusion.
Methods: From August 1989 to December 1999 patients who underwent urgent CTEA for recent ICA thrombosis were
retrospectively evaluated. Patient data analyzed included age, sex, comorbid risk factors, diagnostic evaluation, opera-
tive procedure, and long-term follow-up with clinical assessment and carotid duplex scan. Neurologic status was eval-
uated with the Modified Rankin Scale (MRS) before the operation, immediately after the operation, and at 3- to
6-months’ follow-up.
Results: Twenty-nine patients underwent emergency ipsilateral CTEA for acute ICA thrombosis over the last 10 years.
The average age of the patients was 69.9 ± 1.7 years, and 66% were men. Patient risk factors included diabetes (7
[24%]), hypertension (21 [72%]), coronary artery disease (8 [29%]), and history of tobacco abuse (20 [69%]).
Presenting symptoms included cerebrovascular accident (7 [24%]), transient ischemic attack (nonamaurosis) (10
[34%]), crescendo transient ischemic attack (7 [24%]), stroke in evolution (2 [7%]), and amaurosis fugax (3 [10%]).
Diagnostic evaluation included computed tomographic scan (29 [100%]), magnetic resonance imaging/magnetic reso-
nance angiography (4 [14%]), duplex scan evaluation of the carotid arteries (23 [79%]), and cerebral angiography (18
[64%]). Antegrade flow in the ICA was successfully established in 24 (83%) of 29 patients and confirmed with intra-
operative angiography or duplex sonography. Postoperative morbidity included 2 hematomas (7%), 4 transient cranial
nerve deficits (14%), and 1 conversion to hemorrhagic stroke (3.6%), which resulted in the only death (3.6%). MRS
scores averaged 3.4 ± 0.2 preoperatively. Follow-up averaging 74.1 ± 21 months (range, 3-140 months) was obtained
in 27 (93%) patients. Improvement or deterioration was defined as a change in MRS ± 1. Immediately postoperatively,
14 (48%) patients were improved, 2 (7%) deteriorated, and 13 (45%) had no change. At 3 to 6 months, 20 (74%) of
27 patients were improved, seven (26%) had no change, and none deteriorated. Of patients with successful CTEA, 23
(96%) of 24 had a patent ICA on follow-up duplex scan evaluation, and there was no evidence of recurrent ipsilateral
neurologic events at an average of 49 months. 
Conclusion: These data support an aggressive early surgical intervention for acute ICA thrombosis in carefully selected
patients. In the previous decade we reported a 46% success rate for establishing antegrade flow in the ICA long term.
Data from this decade show a 79% (P = .0114) success rate for establishing antegrade flow long term in all patients
undergoing emergency CTEA. New and improved imaging modalities have allowed better patient selection, resulting
in improved outcomes. (J Vasc Surg 2001;33:242-50.)
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the extracranial ICA from August 1989 to December
1999. Urgent CTEA was defined as operative intervention
within 8 days of presentation. Total occlusions that
occurred after carotid bifurcation endarterectomy, trauma,
dissection, or angiographic procedures were excluded, as
were isolated occlusions of the common carotid artery
(CCA). Patients exhibiting a decreased level of conscious-
ness or lethargy were not considered for CTEA.
Patient data analyzed included age, sex, presenting
symptoms, neurologic status, comorbid risk factors, diag-
nostic evaluation, operative procedure, intraoperative
findings, and long-term follow-up. Comorbid risk factors
evaluated included coronary artery disease (CAD), periph-
eral vascular disease, prior cerebral vascular events (tran-
sient ischemic attack [TIA] or cerebrovascular accident
[CVA]), hypertension, diabetes, renal insufficiency (creati-
nine level > 1.5 mg/dL), chronic obstructive pulmonary
disease (COPD), and tobacco use. 
Neurologic status was based on the Modified Rankin
Scale (MRS). This scale consists of six grades, from 0 to 5,
with 0 corresponding to no symptoms and 5 correspond-
ing to severe disability (Table I). Neurologic status was
scored preoperatively, immediately postoperatively, 3 to 6
months postoperatively, and then yearly. Improvement or
deterioration was defined as a change in the MRS ± 1.
Neurologic status at the time of this report was confirmed
with each patient through a telephone interview.
Diagnostic imaging studies were performed with com-
puted tomography (CT) (Siemens Somatom Plus/Plus S;
Siemens, Iselin, NJ); duplex ultrasonography (DU)
(Acuson; Acuson, Mountainview, Calif; or ATL HDI
3000; Advanced Technology Laboratores, Bothell, Wash);
magnetic resonance imaging/magnetic resonance angiog-
raphy (MRI/MRA) (Picker Vista HPQ 1.oT; Picker
International, Cleveland, Ohio, or GE Signa Horizon
LX1.5T; GE Signa Horizon, Milwaukee, Wis); and
catheter angiography (CA) (Siemens Multistar TOP;
Siemens, or Philips Maximus C1250; Philips, Shelton,
Conn). CT scans of the head were performed with a stan-
dard protocol to evaluate for cerebral infarction or hem-
orrhage. The protocol consisted of  4-mm images through
the posterior fossa, then 8 × 8-mm images through the
vertex. DU studies were performed in a laboratory accred-
ited by the Intersocietal Commission for the Accreditation
of Vascular Laboratories, by the use of color duplex scan-
ners (Acuson or ATL HDI 3000; Aucson or Advanced
Technology Laboratories) with standard techniques. The
CCA, ICA, and external carotid artery (ECA) were each
evaluated. Strandness criteria, which have been internally
corroborated at this institution, were used to determine
stenosis or occlusion.
MRI and MRA were used to evaluate the carotid system,
the brain, or both. Standard protocol to evaluate for cerebral
infarction included sagittal and axial T1 images, axial T2
images, axial proton density or fluid attenuated inversion
recovery. In more recent cases axial diffusion–weighted
images have been used. The protocol to evaluate the carotid
and intracranial arterial system included two-dimensional
and three-dimensional time-of-flight MRA through the
neck, three-dimensional time-of-flight through the head,
and more recently, gadolinium bolus fast spoiled gradient
recalled echo MRA through the arch and neck.
CA was done with the digital subtraction technique.
This consisted of four-vessel angiography and evaluation
of the intracranial arterial system. The subclavian or verte-
bral arteries were injected only in select cases depending
on the results of the arch injection. All of these studies
were performed in the interventional radiology suite with
multiplanar imaging.
The anesthetic technique included the use of regional
cervical block or general anesthesia. Stringent control of
perioperative hypertension was used for patients during
their hospitalization. Cerebral perfusion was evaluated for
patients who had general anesthesia with computer-
assisted electroencephalogram (Neurotrac) monitoring.
Standard positioning and operative technique for carotid
endarterectomy (CEA) was used. All patients were
heparinized with an 80 U/kg bolus. Control of the CCA
and ECA only was obtained initially. Next, an arteriotomy
was performed, and if the thrombus could be removed
locally or backbleeding expelled the thrombus, then con-
trol of the ICA was obtained. If backbleeding was not
achieved or deemed to be inadequate, then a Fogarty
thrombectomy catheter was used on a selective basis with
2F or 3F balloons. Shunting was performed on a selective
basis. Arteriotomies were repaired primarily or with poly-
ester fiber (Dacron) patch angioplasty. Intraoperative eval-
uation of the endarterectomized ICA was performed with
either duplex sonography or angiography. All patients
were observed in an intensive care unit setting for at least
the first 24 hours postoperatively. All patients were given
an infusion of dextran (20%/500 mL) at a rate of 20 cc/h
for 24 hours postoperatively. Blood pressure was moni-
tored continuously with arterial catheterization and main-
Table I. Modified Rankin Scale
Level Description
0 No symptoms
1 No significant disability, despite symptoms; able to perform all usual duties and activities
2 Slight disability; unable to perform all previous activities but able to look after own affairs without assistance
3 Moderate disability; requires some help, but able to walk without assistance
4 Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance
5 Severe disability; bedridden, incontinent, and requires constant nursing care and attention
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tained at 130 to 160 mm Hg systolic. Mannitol at 0.5 to
1 g/kg every 6 hours for 24 to 48 hours and dexametha-
sone at 10 mg intraoperatively and 4 mg every 6 hours for
24 to 48 hours became standard neuroprotective therapies
over the study period.
Kaplan-Meier tables were created in accordance to the
revised recommendations of the Ad Hoc Committee on
Reporting Standards for the Society for Vascular
Surgery/International Society for Cardiovascular Surgery.
Intergroup comparisons of proportional data were made
with χ2 analysis. Differences were considered significant if
the P value was less than .05.
RESULTS
Twenty-nine patients were identified as having under-
gone urgent CTEA for acutely symptomatic ICA occlu-
sion. The average age of these patients at presentation was
69.9 ± 1.7 years (range, 48-84 years). There were 10
women (34%) and 19 men (66%). Comorbid risk factors
in these patients included CAD in 8 (28%), prior cerebral
vascular event in 1 (3.4%), hypertension in 21 (72%), dia-
betes mellitus in 7 (24%), renal insufficiency in 1 (3.4%),
COPD in 2 (7%), and tobacco use in 20 (69%) (Table II).
Presenting symptoms included CVA in 7 (24%), single
TIA in 10 (34%), crescendo TIA in 7 (24%), stroke in evo-
lution in 2 (7%), and amaurosis fugax in 3 (10%) (Table
III). TIA was defined as a single ipsilateral hemispheric
neurologic event in which the deficit resolved within 24
hours. Crescendo TIA was defined as multiple similar ipsi-
lateral hemispheric neurologic events with the deficit con-
tinuing to resolve within 24 hours. Any ipsilateral
hemispheric neurologic event that lasted more than 24
hours was termed a CVA. The preoperative MRS score was
3.4 ± 0.2 (range, 1-5). The average time from onset of
symptoms to endarterectomy was 39 hours (range, 5-192
hours; median, 22.5 hours). Neurologic exclusion criteria
for urgent CTEA included depressed level of conscious-
ness, profound neurologic deficit, and significant lethargy.
Diagnostic imaging varied over the 10-year study
period. In the studies CT scan, MRI, or both of the head
and imaging of the cervical carotid circulation were used
in all 29 patients. Preoperative CT scans were obtained in
all 29 patients. CT scan exclusion criteria for urgent
CTEA include evidence of intracranial hemorrhage, signif-
icant cerebral edema, hemispheric asymmetry, or cerebral
infarct of 1 cm or more. Only five patients (17%) had evi-
dence of acute infarction on CT. MRI was obtained pre-
operatively in only four patients. Exclusion criteria for
CTEA with MRI included intracranial hemorrhage, an
infarction size of 2 cm or more, significant cerebral edema,
or hemispheric asymmetry. Carotid imaging was obtained
by means of MRA in four patients (14%), DU in 23
patients (79%), and CA in 18 patients (64%).
Fogarty embolectomy catheters (2F and 3F) were
needed in 14 cases (48%) to help reestablish backbleeding
and allow for antegrade flow. This procedure was per-
formed under fluoroscopic guidance to avoid injury to the
carotid siphon.
Intraoperative findings included the identification of
intraplaque hemorrhage in 25 cases (86%). A thrombus in
the cervical ICA was noted in 25 cases (86%). The arteri-
otomy was repaired primarily in 25 cases (86%) and with a
woven polyester fiber (Dacron) patch in four (14%).
Backbleeding was established in 24 patients (83%). 
Antegrade flow in the ICA was confirmed intraopera-
tively with the use of DU in 11 cases (46%) and with
angiography in 13 cases (54%). The ICA was ligated in five
patients (17%). Two of these patients had small atretic
ICAs that appeared to be occluded for a long time. In
three patients we could not establish backflow. This sub-
group of patients had an external CEA with primary clo-
sure performed in conjunction with ICA ligation.
Intra-arterial thrombolysis was not attempted. These five
patients presented with TIA (2 [40%]), reversible ischemic
neurologic deficit (2 [40%]), and CVA (1 [20%]).
Immediate postoperative morbidity included 1 case of
tachyarrhythmia (3.4%), 2 neck hematomas (7%), 2 tran-
sient cranial nerve injuries (7%), 1 CVA (3.4%), and 1 con-
version to hemorrhagic stroke (3.4%), which resulted in the
only death (3.4%). There were two neck hematomas (7%);
one required operative evacuation (3.4%) (Table IV). The
one postoperative CVA was in a patient who had the ICA
ligated for what appeared to be an atretic, chronically
Table II. Perioperative risk factors
Risk factor No. patients (%)
CAD 8 (28)
CVA 1 (3)
Hypertension 21 (72)
Diabetes mellitus 7 (24)
Renal failure 1 (3)
COPD 2 (7)
Tobacco use 20 (69)
Table IV. Perioperative morbidity and mortality
Outcome No. patients (%)
Arrhythmia 1 (3)
Hematoma 2 (7)
Cranial nerve injury 2 (7)
Intracerebral hemorrhage 1 (3)
Death 1 (3)
Table III. Clinical presentation
Symptoms No. patients (%)
TIA 10 (34)
Crescendo TIA 7 (24)
CVA 7 (24)
Stroke in evolution 2 (7)
Amaurosis fugax 3 (10)
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occluded vessel. This patient had a more profound upper
extremity hemiplegia. This was resolved by a 3-month 
follow-up evaluation. The cranial nerve injuries were all
transient and included one to the marginal mandibular
nerve and one to the hypoglossal nerve. Eighteen patients
(62%) received mannitol and dexamethasone as neuropro-
tective adjuncts. This practice was instituted over the sec-
ond half of the study period and is now used routinely. The
average length of postoperative stay was 3.2 days (range, 1-
8 days). Twenty-four patients were discharged home, two
were discharged to a skilled nursing unit, and two were dis-
charged to an extended care facility.
Patient follow-up, which averaged 74.1 ± 21 months
(range, 3-140 months), was obtained in 27 patients
(93%). One patient was lost to follow-up after 1 month,
and the other patient died 5 days postoperatively. The
immediate postoperative MRS showed improvement in 14
patients (48%), no change in 13 (45%), and deterioration
in 2 (7%). At 3 to 6 months postoperatively, 20 (74%) of
27 patients were improved, and seven (26%) of 27 were
unchanged. No patient followed up beyond 1 month
showed any deterioration (Table V).
In the 24 patients who had undergone successful
CTEAs, the extracranial ICA remained patent with ante-
grade flow in 23 (96%) patients on follow-up DU at an
average of 49 months (range, 1-168 months) (Table VI).
In addition, none of the 24 patients had evidence of ipsi-
lateral neurologic events during that time. There were
four deaths (14%) in the follow-up period. Two deaths
were due to myocardial infarctions, and two were unex-
plained. These latter patients died in their sleep, and the
request for autopsies was denied. One of the unexplained
deaths occurred in a patient whose attempt at revascular-
ization was unsuccessful. The ICA had been ligated at the
time of surgery, and this patient died 46 months postop-
eratively. In the 29 patients undergoing CTEA, long-term
patency was achieved in 23 (79%). This was an improve-
ment compared with our previous series in which ante-
grade flow on follow-up was achieved in 11 (46%) of 24
patients (P = .0114).
DISCUSSION
CEA has been validated as efficacious for stroke pro-
phylaxis in symptomatic and asymptomatic carotid artery
stenosis.1-3 CEA reduces the mortality rates and increases
stroke-free survival in symptomatic patients if it is per-
formed in a patient population with a perioperative mor-
bidity rate below 5.8%.1 Over the past 35 years the role of
CEA in the setting of acute stroke has not been as clear.
The intracranial risks of reperfusion and hemorrhagic con-
version temper the application of CEA in the setting of an
acute cerebrovascular accident.4-7,13
Although some patients with occlusion of the ICA can
have a catastrophic brain injury, others have only a TIA or
Table V. Neurologic events
Interval No. of No. of neurologic No. patients Failure Cumulative
(mo) carotids events withdrawn or died rate event rate SE
0 29 1 0 0.036 96.4% 3.4%
0.4 28 0 1 0.000 96.4% 3.5%
3 27 0 1 0.000 96.4% 3.5%
6.7 26 0 0 0.000 96.4% 3.6%
13 25 0 0 0.000 96.4% 3.6%
13.1 24 0 0 0.000 96.4% 3.7%
13.8 23 0 0 0.000 96.4% 3.8%
25 22 0 0 0.000 96.4% 3.9%
28 21 0 0 0.000 96.4% 4.0%
28 20 0 0 0.000 96.4% 4.1%
28.4 19 0 0 0.000 96.4% 4.2%
33.4 18 0 1 0.000 96.4% 4.3%
36.1 17 0 1 0.000 96.4% 4.4%
46.9 16 0 0 0.000 96.4% 4.6%
51.6 15 0 0 0.000 96.4% 4.7%
66.9 14 0 0 0.000 96.4% 4.9%
69.4 13 0 0 0.000 96.4% 5.1%
78.1 12 0 1 0.000 96.4% 5.3%
87.9 11 0 0 0.000 96.4% 5.5%
92.5 10 0 0 0.000 96.4% 5.8%
96.4 9 0 0 0.000 96.4% 6.1%
99.8 8 0 0 0.000 96.4% 6.4%
101.9 7 0 0 0.000 96.4% 6.9%
108.6 6 0 1 0.000 96.4% 7.4%
115 5 0 0 0.000 96.4% 8.1%
129.9 4 0 0 0.000 96.4% 9.1%
134.4 3 0 1 0.000 96.4% 10.5%
153.1 2 0 0 0.000 96.4% 12.9%
173 1 0 0 0.000 96.4% 18.2%
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a minor stroke. In other cases there are no immediate
symptoms, and the occluded artery is found incidentally.
This wide range of clinical consequences confirms that
multiple factors influence the outcome and natural history
of an occluded ICA. Nicholls et al14 followed 24 patients
over a 7-year period with unilateral carotid occlusion. The
occlusions were associated with a neurologic event at pre-
sentation in 46% of patients. At a mean follow-up of 39
months after identification of the occlusion, the neuro-
logic event rate was 20% per year. Cote et al15 prospec-
tively followed 47 patients with unilateral carotid artery
occlusion for an average of 34 months. These patients pre-
sented with neurologic symptoms from none to mild. The
neurologic event rate over 34 months was 23.5%. Two
thirds of these events were ipsilateral to the occluded
artery. The stroke rate distal to the occluded artery was 5%
per year, whereas 51% of patients experienced ipsilateral
TIAs during the study period. 
Strokes and TIAs after total occlusion of the ICA have
been attributed to four main pathogenic mechanisms: (1)
emboli into the circle of Willis from the distal end of the
occlusive thrombus; (2) emboli originating from a residual
internal artery stump through the ECA; (3) emboli from
ipsilateral CCA, ECA, or aorta through collateral chan-
nels; or most likely, (4) hypoperfusion distal to the occlu-
sion.13,16-19 The capacity of the cerebral circulation to
develop collateral flow depends on autoregulation, which
is dependent on native cerebral collateral anatomy.
Impairment of autoregulation leads to chronic cerebral
hypoperfusion, and therefore, neurologic function
becomes susceptible to changes in blood pressure and car-
diac output.16 Grubb et al18 have used positron emission
tomography to delineate a subgroup of patients at risk for
this type of cerebral hemodynamic failure. Their data
showed a 15.8% incidence of ipsilateral stroke at 2 years
for all patients. In patients identified as having cerebral
hemodynamic failure as diagnosed with increased oxygen
extraction measured with positron emission tomography
scan, the incidence of ipsilateral neurologic event was
26.5%. This study further defined a subgroup of patients
who would benefit from revascularization.
The role of surgical therapy to improve the natural his-
tory of ICA occlusion has been visited previously.4-12 In
the 1960s and 1970s, before CT, in multiple series there
were reports of surgical morbidity and mortality rates of
16% to 51% for thromboendarterectomy of the occluded
ICA.4-7 These studies also identified a subgroup of
patients who fared better than the group as a whole, albeit
without the sophistication of Grubb et al.4-7,20-24 This
subgroup included patients who presented early in their
course and without profound neurologic deficits. The
selection of this subgroup has been further delineated with
Table VI. Patency
No. of No. patients
Intreval No. of carotids occluded withdrawn Failure Cumulative
(mo) carotids or failed to open or died rate patency rate SE
0 29 1 0 0.034 96.4% 3.4%
0 28 1 0 0.036 93.0% 4.7%
0 27 1 0 0.037 89.5% 5.6%
0 26 1 0 0.038 89.4% 5.7%
0 25 1 0 0.040 85.8% 6.5%
0.2 24 0 1 0.000 85.8% 6.6%
2.6 23 0 0 0.000 85.8% 6.7%
2.8 22 0 0 0.000 85.8% 6.9%
3.0 21 0 1 0.000 85.8% 7.0%
6.1 20 0 0 0.000 85.8% 7.2%
8.8 19 0 0 0.000 85.8% 7.4%
13.0 18 0 0 0.000 85.8% 7.6%
22.9 17 0 0 0.000 85.8% 7.8%
23.7 16 0 0 0.000 85.8% 8.1%
24.6 15 0 0 0.000 85.8% 8.3%
33.4 14 0 1 0.000 85.8% 8.6%
35.3 13 0 0 0.000 85.8% 9.0%
36.1 12 0 1 0.000 85.8% 9.3%
40.8 11 0 0 0.000 85.8% 9.7%
55.7 10 0 0 0.000 85.8% 10.2%
61.6 9 0 0 0.000 85.8% 10.8%
65.0 8 0 0 0.000 85.8% 11.4%
75.3 7 1 0 0.143 73.6% 14.3%
77.9 6 0 1 0.000 73.6% 15.4%
85.8 5 0 0 0.000 73.6% 16.9%
108.6 4 0 1 0.000 73.6% 18.9%
134.2 3 0 1 0.000 73.6% 21.8%
143.1 2 0 0 0.000 73.6% 26.7%
167.6 1 0 0 0.000 73.6% 37.8%
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the newer imaging modalities made available over the last
decade. The routine use of CT and MRI have helped iden-
tify patients with dense infarcts versus those with a poten-
tially recoverable ischemic penumbra. Improvements in
contrast angiography, DU, and MRA have helped differ-
entiate chronic from acute carotid occlusive disease. The
improvements in contrast angiography, especially digital
subtraction angiography, have provided a better assess-
ment of the carotid bifurcation, intracranial arterial
anatomy, and patency of the carotid siphon. The B-mode
imaging definition of current ultrasound scan devices has
significantly improved over the last 15 to 20 years.
Thrombus that appears retracted and brightly echogenic is
undoubtedly chronic. Also, patients with a small atretic-
appearing ICA, in which the ICA is disproportionately
smaller than the CCA or ECA, are likely to have a chron-
ically occluded ICA. These factors have allowed for better
preoperative patient selection. A patent intracranial ICA in
the supraophthalmic region is predictive for the successful
establishment of patent antegrade flow. MRA is helpful in
demonstrating patency in this portion of the distal ICA.
Intraoperative angiography should be performed after the
establishment of antegrade ICA flow. This allows for the
identification of intracranial atherosclerotic disease, which
may affect long-term patency. This was predictive for the
one postoperative occlusion in this series. When compared
with our previous series, our long-term patency improved
from 46% (11/24) to 79% (23/29; P = .0114). We think
this is a result of improved patient selection. Experience
and progress in imaging enhancement have provided
improved patient selection over the last 20 years.
The Rankin scale was the first comprehensive func-
tional assessment scale published for use on stroke sur-
vivors. It is an ordinal scale that provides an overall
estimate of the level of functional dependence in a given
stroke survivor. The MRS measures independence rather
than performance of specific tasks.25 Newer, more sophis-
ticated indexes, such as the National Institutes of Health
stroke scale, may be more appropriate for prospective
studies. However, because our study was retrospective, we
used the MRS as an objective assessment. 
These results support the concept that carotid artery
surgery may be performed safely in properly selected patients
with acute ICA occlusion. It is thought that ongoing hyper-
tension and cerebral edema are the primary contributing fac-
tors resulting in the conversion of a bland infarct to a
hemorrhagic infarct.6,7,13,19,26 Intensive patient manage-
ment with precise control of hypertension, anticoagulation,
and adjunctive means of reducing intracranial pressure is a
means of diminishing the risk of hemorrhagic conversion.
We have used mannitol and steroids (dexamethasone) to
decrease intracranial pressure, to act as oxygen-free radical
scavengers, and to provide membrane stabilization. We think
that these therapies have been useful neuroprotective
adjuncts in the postoperative care of these patients.
We previously reported a series of 24 patients under-
going surgical exploration for suspected recent total occlu-
sion of the ICA. Antegrade flow was established in 15
(63%). There was no aggravation of preoperative neuro-
logic deficits, there were no hemorrhagic conversions, and
there were no operative deaths.8 McCormick et al9
reviewed 42 patients with surgically managed symptomatic
ICA occlusion. Antegrade flow was established in 24
(56%), there was one postoperative neurologic event
(2.3%), and one patient had worsening of a preoperative
neurologic deficit (2.3%). There were no hemorrhagic con-
versions and no postoperative deaths.9 The one hemor-
rhagic conversion in this series resulted in the only death.
This patient had a dense neurologic deficit and significant
cerebral edema on CT. The patient did not undergo CTEA
until 8 days after presentation, at the recommendation of
the referring neurologist. This represented an aggressive
approach to a high-risk patient, which was a violation of
our protocol. This supports the need for careful patient
selection. Urgent CTEA should not be attempted in
patients with profound neurologic deficits or a depressed
level of consciousness. Table VII summarizes the outcomes
of the few modern series in which surgical restoration of
ICA flow after recent ICA occlusion has been reported.
These data support an aggressive approach to a select
subgroup of symptomatic patients presenting with sus-
pected recent total occlusion of the ICA. Proper identifi-
cation should include patients presenting with mild or
improving neurologic deficits, no evidence of bland or
Table VII. Outcome of patients for surgical restoration of the ICA flow in six series*
Successful
Authors & year No. of cases Exclusion criteria Morbidity Mortality reopening
Kusunoki et al, 1978 14 Profound deficit, major medical problem, severe 1 (7) 0 NA
angiographic disease
Hugenholtz & Elgie, 1980 35 ICH, drowsy, major deficit 4 (11) 0 19 (54)
Hafner & Tew, 1981 47 Profound deficit, ICH, symptoms > 45 d 0 0 32 (68)
McCormick et al, 1992 43 Profound deficit, ICH, chronic disease with poor reflux 1 (2) 0 24 (56)
Welling et al, 1984 24 Profound deficit, ICH 1 (4) 0 15 (63)
Kasper et al, 2000 29 Profound deficit, ICH 4 (14) 1 (3) 24 (83)
Totals 192 11 (6) 1 (0) 114 (64)
*All six series used similar exclusion criteria. Numbers in parentheses are percentages of the total in each study.
ICA, Internal carotid artery; ICH, intracerebral hemorrhage; NA, not available.
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hemorrhagic infarct on CT, and a suggestion of recent
ICA thrombosis with a normal-appearing patent distal
ICA. The preoperative use of modern cerebral imaging
techniques and the stringent perioperative control of
hypertension, anticoagulation, and intracerebral pressure
have virtually eliminated the risk of hemorrhagic conver-
sion in appropriately selected patients (Fig 1). Urgent
CTEA is technically easier when performed early and
Fig 1. Preoperative flowchart. ICA, Internal carotid artery; MRA, magnetic resonance angiography.
Fig 2. Intraoperative flowchart. CEA, Carotid endarterectomy; ICA, internal carotid artery.
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before thrombus organization and adherence (Fig 2).
With proper selection and technique, urgent surgical
treatment for ICA occlusion has a better long-term neu-
rologic outcome than as shown in present natural history
studies. These data show that urgent CTEA for suspected
recent total occlusion of the ICA is safe and improves
stroke-free survival in a selected group of patients. 
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DISCUSSION
Dr Jerry Goldstone (Cleveland, Ohio). At the 31st annual
meeting of this society in 1983, Welling and his colleagues pre-
sented a similar series of carotid explorations in 24 asymptomatic
patients with internal carotid artery occlusion. These operations
were performed between 5 and 21 days after the onset of the neu-
rologic deficit. Successful restoration of flow within the internal
carotid artery was accomplished in 63% of the cases with no peri-
operative new strokes or mortality. So, what, if anything, is dif-
ferent about the current series and what has been learned in the
last 20 years? Certainly the current series of patients had better
documentation not only of their neurologic status but also of the
status of their arteries and brains because of the availability and
use of contemporary imaging techniques. Reestablishment of
flow in the internal carotid artery was even more successful, being
achieved in 83% in this series compared with 63% in the earlier
one with only one stroke and that occurred in a patient in whom
flow could not be reestablished. This patient had a dense neuro-
logic deficit that was 8 days old at the time of the operation. I sus-
pect that a similar patient would not be operated on. The authors
believe, as I do, that acute profound neurologic deficits are a con-
traindication to carotid surgery. Clearly, the most important fea-
ture in attaining results of this caliber is the careful selection of
patients and the proper timing of the operation. The authors
emphasize this in their manuscript. This leads to my first ques-
tion: The interval from onset of symptoms to operation ranged
from 5 to 192 hours. Frankly, I don’t consider an operation per-
formed 8 days into an illness as being urgent, but nevertheless,
what was the distribution of preoperative intervals according to
patient categories, and when is the optimum time to proceed? 
I have two additional comments and questions:
1. Five of the 29 patients had internal carotid arteries that
could not be reopened. Two were described as atretic and
chronically occluded. These patients were not likely to have
benefited from carotid exploration, and in fact, one was the
only mortality in the series. Do the authors have criteria to
identify these patients? They describe a patent internal
carotid artery above the ophthalmic artery as predictive for
successful establishment of patent antegrade flow. Our own
criteria include visualization of retrograde flow in the inter-
nal carotid artery down past the petrous portion of the tem-
poral bone. Was this seen on any of your patients, and do
you think that it would be helpful in this regard? 
2. Twenty-five (86%) of the 29 patients had thrombus within
the lumen of the internal carotid artery. In the North
American Symptomatic Carotid Endarterectomy Trial, the
only subgroup of patients who did not achieve benefit from
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surgery in the high-grade stenosis group was the subgroup
of those who had a fresh thrombus in the lumen of the
artery. The perioperative stroke morbidity was approxi-
mately 25% in both the medically and surgically treated
patients. How can the authors reconcile their data with
those of NASCET? 
Several technical points about the operations deserve empha-
sis. The authors were careful not to clamp the internal carotid
artery until after patency was reestablished. This avoids the poten-
tially disastrous complication of fracturing the thrombus and per-
mitting distal embolization. They also used small embolectomy
catheters to extract thrombus from the distal extracranial internal
carotid artery. Although this is often said to be an ill-advised thing
to do, they did it under fluoroscopic control so that they knew
where the tips of the catheters were at all times. Parenthetically,
this is another example of the benefits of using intraoperative dig-
ital fluoroscopy. Lastly, they used intraoperative imaging, duplex
ultrasound, or arteriography to ensure an adequate technical
results in each of these cases. 
Perhaps more important was the careful attention to control
of blood pressure in the perioperative period. This series and the
previous one clearly debunk the myth that reperfusion alone con-
verts anemic into hemorrhagic cerebral infarction. This is no
doubt, however, what reperfusion plus hypertension does. 
Finally, I believe the most important lesson from this paper is
that there have been no late strokes in this series of patients after
an average follow-up of 74 months. This stands in stark contrast
to the natural history of internal carotid occlusion for which the
subsequent ipsilateral stroke rate ranges from 2% to 6% per year. I
have long considered carotid occlusion to be a another con-
traindication to carotid surgery, but occlusion of the internal
carotid artery is clearly not the end of the story for a substantial
number of patients. In a prospective, blinded longitudinal cohort
study of 81 symptomatic patients with internal carotid artery
occlusion studied with PET scans, increased cerebral oxygen
extraction or what is known as stage two hemodynamic failure,
was identified as an independent risk factor for subsequent
ischemic strokes that occurred at an annual rate of greater than
10%. Although the current study did not include PET scan data,
I suspect that many of the patients would meet these criteria and
that this explains the long-identifiable subgroup of patients for
whom early, if not urgent, carotid thromboendarterectomy could
have highly beneficial results. 
I appreciate the opportunity to discuss this stimulating work
and congratulate Dr Kasper for an excellent presentation.  
Dr Gregory C. Kasper. Thank you for your kind comments,
Dr Goldstone. 
With regard to preoperative intervals, there was quite a vari-
ation. Three of 29 patients were operated on at 6, 7, and 8 days
postpresentation. This was the result of referral patterns. If you
eliminate those three outliers, all patients were operated on within
24 hours of presentation. 
The average time to CEA in patients with compelling neuro-
logic events or unstable symptomatology was 38 hours. There
was one patient evaluated 7 days postpresentation who had
become neurologically unstable after initial discharge. When you
eliminate this outlier, the subgroup underwent CEA prior to our
involvement at an average 20 hours postpresentation. 
There were five patients in whom we were unable to reestablish
antegrade carotid flow; two had small, chronically atretic vessels. No
attempt was made to open these vessels. In the remaining three
patients we were unable to establish carotid backbleeding intraoper-
atively. We believe this was the result of propagated thrombus to the
carotid siphon. It is important to be cautious with thrombectomy
catheters in that area to prevent carotid cavernous fistulas. 
Regarding your question about the NASCET subgroup,
which showed a significant increased stroke rate in patients, if
patients present with a tight stenosis and antegrade carotid flow,
manipulation of the internal carotid artery can dislodge material
and result in an embolic stroke. In an occluded internal carotid
artery back pressure supports retrograde flow, which theoretically
decreases the risk of emboli. In 52% of our patients, after the
carotid arteriotomy, the thrombus was easily expelled into the
operative field because of back pressure.
Lastly, with regard to imaging, we attempt to image the
intracranial portion of the internal carotid artery below the level
of the ophthalmic artery. We use gadolinium-enhanced MRA for
this. A few tiny branches of the petrous portion of the internal
carotid artery have been described, and these may maintain flow
in this portion of the ICA. If patency is demonstrated, there is an
excellent chance of establishing antegrade flow in the ICA. I
believe our data support this approach. 
Dr John M. Porter (Portland, Ore). Let me ask a quick ques-
tion in the meantime. What size was the balloon catheter, and did
you inject contrast into the balloon so you could see it?
Dr Kasper. Yes, this is an excellent point. We diluted the con-
trast 20% with saline. We perform balloon thrombectomy with a
2F or 3F Fogarty catheter. We only used Fogarty thrombectomy
in 48% of the patients in the series. 
Dr Porter. And I assume you did not recognize any creation
of a carotid cavernous fistula?
Dr Kasper. We did not. In the previous series from our insti-
tution, there was one patient with a carotid-cavernous fistula who
was treated with a detachable balloon.
Dr M. Ashraf Mansour (Maywood, Ill). My question is, what
was the status of the opposite side? How many patients had a con-
tralateral occlusion? 
Also, did you have any patients who initially got worse, the
stroke got worse, and then got better as they recovered? 
Dr Kasper. With regard to status of the contralateral internal
carotid artery, there were no patients with contralateral occlusion.
With regard to postoperative neurologic events, there was
only one CVA in a patient whose ICA was ligated. This patient
had resolution of this neurologic deficit at 3 months. We believe
these patients are at risk for watershed infarcts due to decreased
or altered cerebral hemodynamics. Early revascularization, if pos-
sible, lessens this risk.
Dr Stanley O. Snyder, Jr (Nashville, Tenn). I applaud your
efforts here, and I agree with a lot of the things you’ve actually done. 
My question is, once you identify these patients, do you then
treat them as an emergency and do them as quickly as you have
the tests completed, or do you give the patient heparin and do
them electively the next day?
Dr Kasper. When we evaluate these patients, they’re already on
heparin. It is important to put the diagnostic measures into high
gear and, if possible, perform CEA as soon as possible.
It’s been shown in previous studies that success is greatest if
the thrombectomy and CEA are performed early.
